1. Home
  2. PFBC vs NTLA Comparison

PFBC vs NTLA Comparison

Compare PFBC & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFBC
  • NTLA
  • Stock Information
  • Founded
  • PFBC 1991
  • NTLA 2014
  • Country
  • PFBC United States
  • NTLA United States
  • Employees
  • PFBC N/A
  • NTLA N/A
  • Industry
  • PFBC Major Banks
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PFBC Finance
  • NTLA Health Care
  • Exchange
  • PFBC Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • PFBC 1.1B
  • NTLA 1.2B
  • IPO Year
  • PFBC 1998
  • NTLA 2016
  • Fundamental
  • Price
  • PFBC $93.21
  • NTLA $11.57
  • Analyst Decision
  • PFBC Hold
  • NTLA Buy
  • Analyst Count
  • PFBC 3
  • NTLA 20
  • Target Price
  • PFBC $103.67
  • NTLA $32.30
  • AVG Volume (30 Days)
  • PFBC 61.4K
  • NTLA 3.9M
  • Earning Date
  • PFBC 10-20-2025
  • NTLA 11-06-2025
  • Dividend Yield
  • PFBC 3.19%
  • NTLA N/A
  • EPS Growth
  • PFBC N/A
  • NTLA N/A
  • EPS
  • PFBC 9.51
  • NTLA N/A
  • Revenue
  • PFBC $267,978,999.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • PFBC $2.56
  • NTLA $8.32
  • Revenue Next Year
  • PFBC $3.42
  • NTLA N/A
  • P/E Ratio
  • PFBC $9.88
  • NTLA N/A
  • Revenue Growth
  • PFBC 1.62
  • NTLA 14.99
  • 52 Week Low
  • PFBC $71.90
  • NTLA $5.90
  • 52 Week High
  • PFBC $99.78
  • NTLA $23.76
  • Technical
  • Relative Strength Index (RSI)
  • PFBC 48.26
  • NTLA 52.67
  • Support Level
  • PFBC $94.28
  • NTLA $10.89
  • Resistance Level
  • PFBC $95.23
  • NTLA $12.03
  • Average True Range (ATR)
  • PFBC 1.81
  • NTLA 0.63
  • MACD
  • PFBC -0.22
  • NTLA 0.01
  • Stochastic Oscillator
  • PFBC 11.21
  • NTLA 43.49

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: